Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Swiss Life Holding AG ADR buy Traumtanz

Start price
€20.79
03.03.21 / 70%
Target price
€22.00
03.03.22
Performance (%)
5.82%
End price
€22.00
02.04.21
Summary
This prediction ended on 02.04.21 with a price of €22.00. The BUY prediction by Traumtanz finished with a performance of 5.82%. Traumtanz has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Swiss Life Holding AG ADR - - - -
iShares Core DAX® 0.160% -1.640% 12.016% 15.557%
iShares Nasdaq 100 -3.020% -4.715% 37.102% 42.685%
iShares Nikkei 225® -2.519% -7.621% 18.066% 2.904%
iShares S&P 500 -1.377% -2.809% 26.536% 41.689%

According to Traumtanz what are the pros and cons of Swiss Life Holding AG ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Good rating
positive Cash Flow expected
Standard Investments for future growth
Very valuable balance sheet
Very capable Management
Very good company culture
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Well known brand
Very Future proof/growth oriented business model
Cons

Comments by Traumtanz for this prediction

In the thread Swiss Life Holding AG ADR diskutieren
Prediction Buy
Perf. (%) 5.82%
Target price 22.000
Change
Ends at

Buy mit Kursziel 22,0

Stabilität fürs Depot?

In the thread Trading Swiss Life Holding AG ADR
Prediction Buy
Perf. (%) 5.82%
Target price 22.000
Change
Ends at 03.03.22

Buy beendet

Stopped prediction by Traumtanz for Swiss Life Holding AG ADR

buy
Swiss Life Holding AG ADR

Start price
Target price
Perf. (%)
€15.38
07.08.20
€18.00
04.11.21
10.74%
11.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation